Ignite Creation Date:
2025-12-24 @ 10:32 PM
Ignite Modification Date:
2026-02-08 @ 9:57 PM
Study NCT ID:
NCT05323435
Status:
COMPLETED
Last Update Posted:
2023-04-25
First Post:
2022-04-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Immunogenicity and Safety Study of Recombinant Two-Component COVID-19 Vaccine (CHO Cell)(ReCOV)
Sponsor:
Jiangsu Rec-Biotechnology Co., Ltd.